Gain-of-function PDGFRA mutations, earlier reported in gastrointestinal stromal tumors, are common in small intestinal inflammatory fibroid polyps. A study of 60 cases
- 1 August 2009
- journal article
- Published by Elsevier BV in Laboratory Investigation
- Vol. 22 (8), 1049-1056
- https://doi.org/10.1038/modpathol.2009.62
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Site-dependent differential KIT and PDGFRA expression in gastric and intestinal gastrointestinal stromal tumorsLaboratory Investigation, 2007
- Intestinal Neurofibromatosis Is a Subtype of Familial GIST and Results From a Dominant Activating Mutation in PDGFRAGastroenterology, 2006
- KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumoursEuropean Journal Of Cancer, 2006
- Predicting HER2 status of breast cancer from basic pathology features: HER2 status of 1500 breast cancers determined by immunohistochemistry and flourescence In situ hybridisation with pathology correlationEuropean Journal of Cancer, 2002
- Effect of the Tyrosine Kinase Inhibitor STI571 in a Patient with a Metastatic Gastrointestinal Stromal TumorNew England Journal of Medicine, 2001
- Gain-of-Function Mutations of c- kit in Human Gastrointestinal Stromal TumorsScience, 1998
- Multiple and recurrent inflammatory fibroid polyps in a Devon family ('Devon polyposis syndrome'): an update.Gut, 1992
- Human PDGFA receptor gene maps to the same region on chromosome 4 as the KIT oncogeneGenes, Chromosomes and Cancer, 1989
- Multiple and recurrent inflammatory fibroid polyps in three generations of a Devon family: a new syndrome.Gut, 1984
- Recurrent familial inflammatory fibroid polyps of the small intestine.Journal of Clinical Pathology, 1969